Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Search
Who we are
NCF International
Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Home
Politics & Business
Page 4
Politics & Business
Biosimilars: the strategic imperative to balance between the needs for innovation...
Giuliana Miglierini
15 May 2019
Transforming Big Pharma’s model
Giuliana Miglierini
16 April 2019
Horizon Europe: time to look at the future of European research
Giuliana Miglierini
21 March 2019
Emerging trends for the pharmaceutical market
Giuliana Miglierini
20 February 2019
Inequalities in the access to healthcare in Europe
Giuliana Miglierini
15 January 2019
Hard Brexit, soft Brexit, no Brexit?
Giuliana Miglierini
11 December 2018
The peril road of the SPC manufacturing waiver
Giuliana Miglierini
21 November 2018
The business of AI-based sharing of healthcare data
Giuliana Miglierini
23 October 2018
The sustainability of the business model for advanced therapies
Giuliana Miglierini
20 September 2018
Italy has overtaken Germany for pharmaceutical production
Giuliana Miglierini
4 September 2018
1
...
3
4
5
Page 4 of 5